Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

HI Dado, are you saying that we could have one trial for all the diseases...that would surprise me if true. I think the reason for the measured pace is as mgt states:

“We look forward to initiating these placebo-controlled clinical trials. The respective trial designs are based on broad genomic and biomarker characterization, pharmacokinetic and pharmacodynamic modeling including data from patients in previous ANAVEX™ 2-73 trials, as well as preclinical translational science. To our knowledge, this is the first use of this approach in the design of clinical trials for Alzheimer’s disease, Parkinson’s disease and Rett syndrome, and marks a shift towards advancing implementation of precision medicine for these and other neurodegenerative and neurodevelopmental diseases."

or in short, using genetic testing to select the people most likely to respond.